Cialis (tadalafil): a new treatment for erectile dysfunction.
Oral phosphodiesterase inhibitors have become the mainstay of treatment for erectile dysfunction. A novel and potent phosphodiesterase inhibitor, tadalafil, known as Cialis, has been introduced in the UK as an alternative to the other currently available phosphodiesterase inhibitors for the treatment of erectile dysfunction.
Institute of Urology and Nephrology, University College London, London W1P 7NN.
S
S
Minhas
J S
JS
Kalsi
D J
DJ
Ralph
D002243:Carbolines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D017326:Clinical Trials, Phase III as Topic; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D010410:Penile Erection / Q000187:drug effects / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000068581:Tadalafil
D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil